Renaud Ronald C JR's Form 4 filing
Cerevel Therapeutics Holdings, Inc. (CERE) · filed Aug 7, 2023
- Accession no.
- 0000950170-23-039169
- Filed
- Aug 7, 2023
- Trade date
- Aug 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $2.01M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Renaud Ronald C JRCIK 0001354434 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | Common Stock | PPurchaseAcquired | +83,857 | $23.96 | +$2,009,213.72 | 83,857 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.